• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prophylactic anticoagulation for patients in hospital with covid-19.

作者信息

Hunt Beverley J, De Paula Erich V, McLintock Claire, Dumantepe Mert

机构信息

Thrombosis and Haemophilia Centre, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK

School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.

出版信息

BMJ. 2021 Feb 19;372:n487. doi: 10.1136/bmj.n487.

DOI:10.1136/bmj.n487
PMID:33608304
Abstract
摘要

相似文献

1
Prophylactic anticoagulation for patients in hospital with covid-19.新冠肺炎住院患者的预防性抗凝治疗。
BMJ. 2021 Feb 19;372:n487. doi: 10.1136/bmj.n487.
2
Empiric Therapeutic Anticoagulation and Mortality in Critically Ill Patients With Respiratory Failure From SARS-CoV-2: A Retrospective Cohort Study.经验性治疗抗凝与 COVID-19 所致呼吸衰竭危重症患者的死亡率：一项回顾性队列研究。
J Clin Pharmacol. 2020 Nov;60(11):1411-1415. doi: 10.1002/jcph.1749. Epub 2020 Sep 30.
3
Further Evidence Supporting the Use of Prophylactic Anticoagulation in Hospitalized Patients With COVID-19.支持对COVID-19住院患者使用预防性抗凝治疗的进一步证据
JAMA Netw Open. 2021 Jun 1;4(6):e2112403. doi: 10.1001/jamanetworkopen.2021.12403.
4
Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia.新冠病毒肺炎住院患者的抗凝强度与生存率
Thromb Res. 2020 Dec;196:375-378. doi: 10.1016/j.thromres.2020.09.030. Epub 2020 Sep 23.
5
Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation.接受预防性抗凝治疗的新冠肺炎住院患者的静脉血栓栓塞症
Mayo Clin Proc. 2020 Oct;95(10):2291-2293. doi: 10.1016/j.mayocp.2020.08.014. Epub 2020 Aug 13.
6
High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia.重症新型冠状病毒肺炎的大剂量预防性抗凝治疗
Chest. 2021 Jul;160(1):e94-e95. doi: 10.1016/j.chest.2021.02.036.
7
Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence.新冠病毒肺炎中的抗凝治疗：随机试验应在热情与证据之间找到平衡。
Thromb Res. 2020 Dec;196:638-640. doi: 10.1016/j.thromres.2020.09.033. Epub 2020 Oct 8.
8
Acute cor pulmonale from saddle pulmonary embolism in a patient with previous COVID-19: should we prolong prophylactic anticoagulation?新冠肺炎后患者发生 saddle 型肺栓塞致急性肺心病：我们是否应延长预防性抗凝？
Int J Infect Dis. 2020 Aug;97:299-302. doi: 10.1016/j.ijid.2020.06.039. Epub 2020 Jun 13.
9
[Anticoagulation in SARS-CoV-2 infection: state of the art and management in patients with home treatment].[新型冠状病毒2型感染中的抗凝治疗：居家治疗患者的现状与管理]
Rev Chilena Infectol. 2021 Jun;38(3):461-462. doi: 10.4067/S0716-10182021000300461.
10
Anticoagulation in COVID-19: DDI Perspective.COVID-19中的抗凝治疗：药物相互作用视角
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620959457. doi: 10.1177/1076029620959457.

引用本文的文献

1
Approach to Thromboprophylaxis for Prevention of Venous Thromboembolism in COVID-19: Global Updates and Clinical Insights from India.COVID-19 患者预防静脉血栓栓塞症的血栓预防方法：全球最新进展及来自印度的临床见解
Clin Pract. 2022 Sep 23;12(5):766-781. doi: 10.3390/clinpract12050080.
2
Calcium dobesilate reduces SARS-CoV-2 entry into endothelial cells by inhibiting virus binding to heparan sulfate.羟苯磺酸钙通过抑制病毒与硫酸乙酰肝素结合来减少 SARS-CoV-2 进入血管内皮细胞。
Sci Rep. 2022 Oct 7;12(1):16878. doi: 10.1038/s41598-022-20973-3.
3
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19.
新冠病毒肺炎患者血栓形成并发症后继发感染的高风险
Open Forum Infect Dis. 2022 Sep 2;9(9):ofac454. doi: 10.1093/ofid/ofac454. eCollection 2022 Sep.
4
When doctors as well as bureaucrats work together!当医生和官僚们携手合作时！
J Family Med Prim Care. 2022 Jun;11(6):3374-3375. doi: 10.4103/jfmpc.jfmpc_419_21. Epub 2022 Jun 30.
5
Hypercoagulation Detected by Rotational Thromboelastometry Predicts Mortality in COVID-19: A Risk Model Based on a Prospective Observational Study.旋转血栓弹力图检测到的高凝状态可预测COVID-19患者的死亡率：一项基于前瞻性观察研究的风险模型
TH Open. 2021 Dec 21;6(1):e50-e59. doi: 10.1055/a-1725-9221. eCollection 2022 Jan.
6
Anticoagulants for people hospitalised with COVID-19.COVID-19 住院患者的抗凝治疗。
Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2.
7
The effect of previous oral anticoagulant use on clinical outcomes in COVID-19: A systematic review and meta-analysis.既往口服抗凝药物使用对 COVID-19 临床结局的影响：系统评价和荟萃分析。
Am J Emerg Med. 2022 Apr;54:107-110. doi: 10.1016/j.ajem.2022.01.059. Epub 2022 Feb 3.
8
Use and misuse of biomarkers and the role of D-dimer and C-reactive protein in the management of COVID-19: A post-hoc analysis of a prospective cohort study.生物标志物的使用和误用以及 D-二聚体和 C 反应蛋白在 COVID-19 管理中的作用：一项前瞻性队列研究的事后分析。
Clinics (Sao Paulo). 2021 Dec 8;76:e3547. doi: 10.6061/clinics/2021/e3547. eCollection 2021.
9
Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic.病毒诱导的炎症性凝血障碍：为另一场疫情做准备。
Thromb Haemost. 2022 Jan;122(1):8-19. doi: 10.1055/a-1562-7599. Epub 2021 Sep 13.
10
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP).成人新型冠状病毒肺炎患者在非重症监护病房的临床管理：来自意大利抗感染治疗学会（SITA）和意大利肺病学会（SIP）的指南
Infect Dis Ther. 2021 Dec;10(4):1837-1885. doi: 10.1007/s40121-021-00487-7. Epub 2021 Jul 30.